Modifier KO

Single Drug Unit-Dose Formulation

Modifier KO identifies a single inhalation drug dispensed in a ready-to-use unit-dose container, supporting accurate Medicare nebulizer medication billing and claim processing.

On This Page

Related Modifiers

Modifier KP

First Drug in Combination

Modifier KQ

Additional Combination Drug

Modifier KX

Policy Requirements Met

What Is Modifier KO?

Modifier KO is a HCPCS Level II modifier used to identify a single drug supplied in a unit-dose formulation for nebulizer treatment.

Medicare uses KO to distinguish single-drug unit-dose inhalation solutions from formulations containing multiple drugs and from concentrated inhalation medications that require dilution.

A unit-dose formulation is supplied in a vial, ampule, or similar container holding the amount typically used for one inhalation treatment. The medication must be sufficiently diluted to administer without adding a separate diluent.

When a single eligible inhalation drug is dispensed in this form, the supplier appends KO to the applicable HCPCS drug code.

Modifier KO is primarily associated with Medicare DMEPOS claims for nebulizer medications used in the home. It identifies the formulation dispensed rather than the number of medications a beneficiary uses throughout the day.

Important: Modifier KO does not establish medical necessity or guarantee Medicare coverage. The medication and nebulizer treatment must meet the applicable coverage requirements.

Quick Reference

Modifier: KO

Meaning: Single Drug Unit Dose

Category: DMEPOS

Type: HCPCS Level II

Used For: Nebulizer Drugs

Billing: Formulation Modifier

When to Use Modifier KO

Single-Drug Unit-Dose Solutions

Report KO when one eligible inhalation drug is dispensed in a ready-to-use unit-dose container.

Nebulizer Medication Claims

Append KO to the applicable HCPCS unit-dose drug code when billing Medicare for qualifying nebulizer medications.

Ready-to-Use Formulations

Use KO when the dispensed medication is already diluted to the concentration required for nebulizer administration.

Individually Packaged Doses

KO applies to eligible single-drug inhalation solutions packaged in individual vials or ampules intended for one treatment.

Pharmacy-Prepared Unit Doses

When a concentrated single inhalation drug is diluted and dispensed in ready-to-use unit-dose containers, the resulting formulation is billed using the appropriate unit-dose code with KO, when applicable.

Important: Modifier selection depends on the formulation actually dispensed, not simply the original drug concentration or packaging purchased by the supplier.

When NOT to Use Modifier KO

Multiple-Drug Formulations

Do not report KO when two or more drugs are combined in the same unit-dose container. KP and KQ generally apply to the individual drug codes, subject to exceptions.

Concentrated Inhalation Solutions

Do not use KO with concentrated drug formulations requiring a separate diluent before administration.

FDA-Approved Combination Product J7620

Do not append KO to HCPCS J7620, which identifies the approved albuterol and ipratropium combination product.

Excluded Drug Codes

Medicare specifically excludes J2545 and Q4074 from KO reporting.

Nebulizer Equipment

KO identifies the medication formulation, not the nebulizer compressor, tubing, mask, or other equipment.

Non-Inhalation Drugs

Do not apply KO to unrelated injectable, oral, or topical medications merely because they are supplied in single-dose containers.

Modifier KO vs KP and KQ

These modifiers distinguish single-drug unit doses from multiple-drug formulations.

Modifier KO – Single Drug

  • Purpose: Identifies one drug in a unit-dose container.

  • When Used: An eligible single-drug nebulizer solution is dispensed ready to use.

  • Billing Focus: Single-drug formulation.

Modifier KP – First Drug

  • Purpose: Identifies one drug in a multiple-drug unit-dose formulation.

  • When Used: Two or more drugs are combined in the same unit-dose container.

  • Billing Focus: First reported drug component.

Modifier KQ – Additional Drug

  • Purpose: Identifies the other drug or drugs in a multiple-drug unit-dose formulation.

  • When Used: Additional drug components are billed separately under their respective unit-dose codes.

  • Billing Focus: Additional drug components.

Key Difference: KO identifies a single-drug formulation. KP and KQ identify individual components of a multiple-drug unit-dose formulation, except when specific billing rules require a combination-product code.

Billing Example

A Medicare beneficiary with chronic obstructive pulmonary disease (COPD) is prescribed albuterol inhalation solution for use with a home nebulizer.

The DMEPOS supplier dispenses 120 ready-to-use unit-dose vials containing only albuterol.

Example – Albuterol Unit-Dose Solution

HCPCS Code: J7613

Medication: Albuterol Inhalation Solution

Concentration: 0.083%

Vial Volume: 3 mL

Drug Amount: 2.5 mg per vial

Quantity Dispensed: 120 Vials

Billing Unit: 1 mg

Units Billed: 300

Modifier: KO

Example Claim: J7613-KO | 300 Units

Each vial contains 2.5 mg of albuterol. Multiplying 120 vials by 2.5 mg results in 300 HCPCS billing units.

Modifier KO identifies the medication as a single-drug unit-dose formulation.

Important: This calculation follows the example in Medicare's Nebulizers Policy Article. Coverage still depends on the prescription, medical necessity, and applicable DME MAC requirements.

Documentation Requirements

Documentation must support the prescribed medication, formulation dispensed, quantity supplied, and medical necessity for nebulizer therapy.

Standard Written Order

Maintain a valid order identifying the prescribed inhalation medication, dosage, frequency, and required information.

Drug Identification

Record the medication name, strength, concentration, and applicable HCPCS code.

Unit-Dose Packaging

Maintain records establishing that the drug was dispensed in ready-to-use unit-dose containers.

Quantity Dispensed

Document the number of vials or ampules supplied and the amount of medication contained in each.

Medical Necessity

Maintain clinical documentation supporting the beneficiary's respiratory condition and need for nebulizer medication.

Refill Documentation

For recurring supplies, maintain required refill requests and documentation supporting continued use.

Documentation Checklist

  • Valid standard written order

  • Medication and concentration verified

  • Single-drug formulation confirmed

  • Unit-dose packaging documented

  • HCPCS code verified

  • Billing units calculated

  • Medical necessity supported

  • Refill requirements satisfied

Medicare Nebulizer Drug Billing Rules

Required Unit-Dose Modifiers

Medicare requires KO, KP, or KQ on applicable unit-dose inhalation drug codes. Claims missing the required modifier are denied as invalid coding, subject to specified exceptions.

Single-Drug Formulations

KO identifies one drug dispensed in a unit-dose container. The medication must be ready for administration without adding a separate diluent.

Multiple-Drug Formulations

When two or more drugs are combined in the same unit-dose container, Medicare generally requires KP on one drug code and KQ on the additional drug codes.

Combination Product Exception

HCPCS J7620 identifies the FDA-approved combination of albuterol and ipratropium. KO, KP, and KQ must not be appended to this code.

Additional Code Exceptions

KO is not used with J2545 or Q4074, even though these codes may describe unit-dose medications.

Concentrated Formulations

KO, KP, and KQ are not used with concentrated inhalation drug codes. Suppliers must select the HCPCS code corresponding to the formulation actually dispensed.

Compounded Unit Doses

When a concentrated drug is diluted and dispensed as a ready-to-use unit dose, the supplier must use the appropriate unit-dose code. The diluent used to prepare the compounded unit dose is not billed separately.

HCPCS Billing Units

Billing units vary by drug code. Some codes are based on milligrams, while others represent a vial or specified dose. Suppliers must calculate units using the actual HCPCS descriptor.

Coverage Requirements

Medicare Part B coverage for nebulizer medications depends on the applicable DME benefit requirements, diagnosis, prescribed treatment, and medical necessity documentation.

Important: The presence of KO does not establish that the medication, quantity, or underlying respiratory condition meets Medicare coverage criteria.

Common Billing Errors & Denials

Omitting Required Modifier KO

Medicare specifically states that applicable unit-dose drug codes submitted without KO, KP, or KQ are denied as invalid coding, except for designated codes.

Using KO for Multiple-Drug Formulations

Reporting KO when two or more drugs are combined in the same unit-dose container misidentifies the formulation. KP and KQ generally apply instead.

Appending KO to J7620

Medicare prohibits KO, KP, and KQ on J7620 because the code already identifies the FDA-approved combination formulation.

Using KO With Excluded Codes

Appending KO to J2545 or Q4074 conflicts with Medicare's specific modifier exceptions.

Using KO With Concentrated Solutions

Concentrated inhalation medications requiring dilution must not be billed using KO. The appropriate concentrated-form HCPCS code should be reported.

Incorrect Drug Billing Units

Billing the number of vials instead of the HCPCS-defined drug quantity can result in incorrect reimbursement. For example, J7613 is billed per milligram rather than per vial.

Billing Diluent Separately

Separately reporting the diluent used to prepare a compounded unit-dose inhalation medication conflicts with Medicare's nebulizer drug billing instructions.

Insufficient Medical Necessity Documentation

An accurate modifier does not replace documentation supporting the medication, prescribed treatment, and applicable Medicare coverage requirements.

Frequently Asked Questions

Does Modifier KO apply when a beneficiary uses more than one nebulizer medication?

Yes. KO may still apply when a beneficiary uses multiple medications, provided the particular unit-dose container being billed contains only one drug. Modifier selection depends on the formulation dispensed, not the total number of medications prescribed.

Can Modifier KO be used for a single drug supplied in a multidose bottle?

No. KO identifies an eligible single-drug unit-dose formulation. A ready-to-use inhalation solution dispensed in a multidose container requires coding under the applicable multidose or other appropriate HCPCS code rather than KO.

ModifierLookup

Your trusted source for CPT and HCPCS modifier explanations, billing guidance, and coding resources

Categories

© 2025. All rights reserved.

Modifiers

Guides

Resources

Trusted Information

Practical Guidance

Accurate, up-to-date, and compliance-focused modifier guidance

Real-world billing examples and coding insights

Built for Professionals

Designed for coders, billers, and healthcare teams

Billing Guidelines

NCCI Edits Guide

Medicare Guidelines

Privacy Policy

Terms & Conditions

Sitemap